China · Delayed Price · Currency is CNY Jiangsu CoWin Biotech Statistics
Total Valuation
SHA:688426 has a market cap or net worth of CNY 3.05 billion. The enterprise value is 2.48 billion.
| Market Cap | 3.05B |
| Enterprise Value | 2.48B |
Important Dates
The next estimated earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688426 has 109.93 million shares outstanding. The number of shares has decreased by -9.06% in one year.
| Current Share Class | 109.93M |
| Shares Outstanding | 109.93M |
| Shares Change (YoY) | -9.06% |
| Shares Change (QoQ) | -0.72% |
| Owned by Insiders (%) | 0.45% |
| Owned by Institutions (%) | 11.31% |
| Float | 34.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.26 |
| PB Ratio | 2.17 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -18.03 |
| EV / Sales | 14.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -19.31 |
Financial Position
The company has a current ratio of 14.33, with a Debt / Equity ratio of 0.02.
| Current Ratio | 14.33 |
| Quick Ratio | 9.07 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.17 |
| Interest Coverage | -154.77 |
Financial Efficiency
Return on equity (ROE) is -9.70% and return on invested capital (ROIC) is -25.59%.
| Return on Equity (ROE) | -9.70% |
| Return on Assets (ROA) | -6.53% |
| Return on Invested Capital (ROIC) | -25.59% |
| Return on Capital Employed (ROCE) | -11.41% |
| Weighted Average Cost of Capital (WACC) | 8.78% |
| Revenue Per Employee | 200,679 |
| Profits Per Employee | -165,331 |
| Employee Count | 770 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 1.92 |
Taxes
In the past 12 months, SHA:688426 has paid 1.92 million in taxes.
| Income Tax | 1.92M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.66% in the last 52 weeks. The beta is 0.83, so SHA:688426's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | +20.66% |
| 50-Day Moving Average | 26.80 |
| 200-Day Moving Average | 24.09 |
| Relative Strength Index (RSI) | 64.02 |
| Average Volume (20 Days) | 1,114,947 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688426 had revenue of CNY 167.17 million and -137.72 million in losses. Loss per share was -1.24.
| Revenue | 167.17M |
| Gross Profit | 70.11M |
| Operating Income | -168.26M |
| Pretax Income | -141.64M |
| Net Income | -137.72M |
| EBITDA | -136.18M |
| EBIT | -168.26M |
| Loss Per Share | -1.24 |
Balance Sheet
The company has 611.02 million in cash and 22.25 million in debt, with a net cash position of 588.77 million or 5.36 per share.
| Cash & Cash Equivalents | 611.02M |
| Total Debt | 22.25M |
| Net Cash | 588.77M |
| Net Cash Per Share | 5.36 |
| Equity (Book Value) | 1.41B |
| Book Value Per Share | 12.65 |
| Working Capital | 1.01B |
Cash Flow
In the last 12 months, operating cash flow was -92.26 million and capital expenditures -36.28 million, giving a free cash flow of -128.54 million.
| Operating Cash Flow | -92.26M |
| Capital Expenditures | -36.28M |
| Free Cash Flow | -128.54M |
| FCF Per Share | -1.17 |
Margins
Gross margin is 41.94%, with operating and profit margins of -100.65% and -82.39%.
| Gross Margin | 41.94% |
| Operating Margin | -100.65% |
| Pretax Margin | -84.73% |
| Profit Margin | -82.39% |
| EBITDA Margin | -81.46% |
| EBIT Margin | -100.65% |
| FCF Margin | n/a |
Dividends & Yields
SHA:688426 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 9.06% |
| Shareholder Yield | 9.06% |
| Earnings Yield | -4.51% |
| FCF Yield | -4.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 12, 2023. It was a forward split with a ratio of 1.2000048.
| Last Split Date | Jun 12, 2023 |
| Split Type | Forward |
| Split Ratio | 1.2000048 |
Scores
SHA:688426 has an Altman Z-Score of 11.21 and a Piotroski F-Score of 3.
| Altman Z-Score | 11.21 |
| Piotroski F-Score | 3 |